Which specific types of stem cells are most commonly used in the treatment of degenerative knee osteoarthritis, and how do their sources, properties, and methods of administration affect the outcomes and effectiveness of the therapy?
2 Likes
Stem cell therapy for knee osteoarthritis generally relies on MSCs due to their regenerative and anti-inflammatory properties. The most common sources are bone marrow and fat tissue, each offering different benefits in terms of cell concentration and harvesting methods. Treatment usually involves a direct joint injection. Outcomes often depend on how advanced the cartilage damage is.
@Noahlee07 The most commonly used stem cells for degenerative knee osteoarthritis are mesenchymal stem cells (MSCs), due to their ability to reduce inflammation and support tissue repair in the joint. These are typically sourced from bone marrow, adipose (fat) tissue, or in some regulated cases, donated umbilical cord tissue.
Bone marrow–derived MSCs are widely used because they are well-studied and collected from the patient, reducing immune risks. Adipose-derived MSCs are easier to obtain and provide strong anti-inflammatory effects. Umbilical cord–derived MSCs are considered highly potent but are used only in regulated settings with strict screening.
The type of stem cell and its source can influence treatment outcomes in terms of potency, regenerative ability, and safety. In most cases, the cells are injected directly into the knee joint to target inflammation and cartilage damage.
Overall, MSCs are preferred because they help reduce pain, improve joint function, and support the body’s natural repair processes, with results depending on disease severity and patient condition.